Certain antibiotics increase the risk of a congenital heart disorder called patency of the ductus arteriosis.

Vanderbilt investigators identify a new therapeutic target for the inflammatory lung disease sarcoidosis.

Stem cells derived from patients with pulmonary arterial hypertension provide a unique resource for studying the molecular defects that cause the disease and testing potential therapies.

Up to 60 percent of patients who receive a stem cell transplant using cells from another donor will develop post-transplant diabetes mellitus, which can increase the rate of complications and death after the procedure.

In some cases, HDL, the "good cholesterol," may not function properly and may actually accelerate atherosclerosis.

Endothelial cells residing in the coronary arteries can function as cardiac stem cells to produce new heart muscle tissue, Vanderbilt University investigators have discovered.

Vanderbilt researchers have discovered that the protein CRADD counteracts inflammatory injury to endothelial cells, which could assist the development of new therapies for inflammatory vascular disorders.